Globally, hepatitis C is included in the public health concern. More than 1.4 million deaths are reported. In 170 million who are infected with HCV worldwide,71 million have serious complications. There is a close relationship between hepatitis C infections among family members with one case. Family members behaviors and exposure to positive family members without precautions are among the risk factor of getting hepatitis C infection. In Rwanda, the burden of Hepatitis C infections reaches to 4% of infected people. High prevalence of hepatitis C infection can be associated with horizontal transmission among household of positive patients for HCV. In Rwanda no data showing the contribution of horizontal transmission of HCV among household members as one of the risk factors to increase the prevalence of HCV. The objective of this study was to determine the prevalence of HCV among the household members living with HCV positive individual, specifically attending centre universitaire de sante public of BUTARE. The study used a descriptive cross-sectional design to assess the prevalence among 30 families having had positive cases for HCV with 180 sample size. With use of questionnires, HCV risk factors were assessed from our participants and from their responses. Purposive sampling was done for HCV rapid test and positive cases sample were confirmed at university teaching hospital of BUTARE with Elisa. From participants tested, 10.8% were tested positive for HCV counting for the prevalence of our study. Our findings are in line with other same studies conducted in Egypt and Iran revealed that there was 14.1%, which is a bit closer to our finding. we have found that unprotected sex with parnters and marital status between infected cases has a big influence to the high prevelence. Based on the findings from our study, 10.8% of our participants tested positive for HCV due to limited education, awareness, and exposure to contributing risk factors about HCV transmission. Key words: Hepatitis C virus,Rwanda,Infections

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

University of Rwanda ethical approval

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript